HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis.

Abstract
Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1/LIR1/ILT2) is an inhibitory receptor broadly expressed on leukocytes and recognizes HLA-class I and human cytomegalovirus UL18. LILRB1 is encoded within the leukocyte receptor complex on 19q13.4, previously implicated to be a susceptibility region to systemic lupus erythematosus (SLE). In this study, we screened for polymorphisms of LILRB1 and examined their association with SLE and rheumatoid arthritis (RA). In the 5' portion of LILRB1, three haplotypes containing four non-synonymous substitutions within the ligand-binding domains and two single nucleotide polymorphisms within the promoter region were identified and designated as PE01-03. In the 3' portion, two haplotypes (CY01, 02) containing a non-synonymous substitution of the cytoplasmic region were identified. CY01 and 02 did not co-segregate with PE01-03. Significant association with susceptibility to SLE or RA was not observed; however, among the subjects not carrying RA-associated HLA-DRB1 shared epitope (SE), LILRB1.PE01/01 diplotype was significantly associated with RA (odds ratio 2.05, P = 0.019 and Pc = 0.038). Gross difference was not observed in the crystal structures, thermostabilities and binding affinities to HLA-class I ligands among LILRB1.PE01-03 haplotype products; however, surface expression of LILRB1 was significantly decreased in lymphocytes and monocytes from the carriers of PE01 haplotype. These findings demonstrated that LILRB1 is highly polymorphic and is associated with susceptibility to RA in HLA-DRB1 SE negative subjects, possibly by insufficient inhibitory signaling in leukocytes. In addition, these observations suggested that the polymorphisms of LILR family members may be substantially involved in the diversity of human immune responses.
AuthorsKimiko Kuroki, Naoyuki Tsuchiya, Mitsunori Shiroishi, Linda Rasubala, Yumi Yamashita, Kunio Matsuta, Toru Fukazawa, Makio Kusaoi, Yoshinori Murakami, Masafumi Takiguchi, Takeo Juji, Hiroshi Hashimoto, Daisuke Kohda, Katsumi Maenaka, Katsushi Tokunaga
JournalHuman molecular genetics (Hum Mol Genet) Vol. 14 Issue 16 Pg. 2469-80 (Aug 15 2005) ISSN: 0964-6906 [Print] England
PMID16014635 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Epitopes
  • Glycoproteins
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • LILRB1 protein, human
  • Leukocyte Immunoglobulin-like Receptor B1
  • Receptors, Immunologic
Topics
  • Adult
  • Antigens, CD (genetics)
  • Arthritis, Rheumatoid (genetics, immunology)
  • Epitopes (genetics)
  • Female
  • Genetic Predisposition to Disease
  • Glycoproteins (genetics)
  • HLA-DR Antigens (genetics, immunology)
  • HLA-DRB1 Chains
  • Haplotypes (genetics)
  • Humans
  • Leukocyte Immunoglobulin-like Receptor B1
  • Lymphocytes (metabolism)
  • Male
  • Middle Aged
  • Monocytes (metabolism)
  • Polymorphism, Genetic
  • Receptors, Immunologic (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: